SCIENCE
May 22, 2012 | By Rosie Mestel, Los Angeles Times
The PSA test should be abandoned as a prostate cancer screening tool, a government advisory panel has concluded after determining that the side effects from needless biopsies and treatments hurt many more men than are potentially helped by early detection of cancers. At best, one life will be saved for every 1,000 men screened over a 10-year period, according to the U.S. Preventive Services Task Force. But 100 to 120 men will have suspicious results when there is no cancer, triggering biopsies that can carry complications such as pain, fever, bleeding, infection and hospitalization.
CALIFORNIA | LOCAL
March 29, 2012 | By Ari Bloomekatz, Los Angeles Times
Los Angeles police will not pursue through the courts scores of motorists with unpaid tickets from the city's defunct red-light camera program. The city Police Commission voted this week to end its contract with the company that operated L.A.'s cameras until they were shut off last summer. And authorities are now planning to reassign a small group of officers who regularly appeared in court to testify in contested photo enforcement cases. With the cancellation of the contract, officers will no longer have easy access to the photo and video evidence that courts require.
CALIFORNIA | LOCAL
May 9, 2011 | Carol J. Williams
On summer nights in the mid-1960s, while black-and-white television crackled elsewhere in his Staten Island home with news of Southern violence and Vietnam, Bobby Lasnik would stretch out in his bedroom to let the righteous soundtrack of the civil rights movement waft into his impressionable teenage soul. Tuned in to WBAI-FM, coming across the water from Manhattan, he heard baleful laments about injustice that he would carry with him for a lifetime. "Suddenly there was someone speaking a certain kind of truth to you. You'd say, 'Wow!
HEALTH
March 22, 2012 | By Melissa Healy, Los Angeles Times
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. Now, a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and will bring misery to some, say two medical investigators. The drug, Aricept 23 mg, is no more effective on the whole than the disappointing ones already on the market - but is more likely to cause gastrointestinal problems, wrote Drs. Steven Woloshin and Lisa Schwartz of Dartmouth Medical College in an article published Thursday in the medical journal BMJ. The new formulation was devised to serve commercial objectives, they say, and was approved despite a poor showing in company-sponsored tests.
OPINION
November 24, 2009 | By David Masci
Today, a century and a half after Charles Darwin published "On the Origin of Species by Means of Natural Selection," the overwhelming majority of scientists in the United States accept Darwinian evolution as the basis for understanding how life on Earth developed. But although evolutionary theory is often portrayed as antithetical to religion, it has not destroyed the religious faith of the scientific community. According to a survey of members of the American Assn. for the Advancement of Science, conducted by the Pew Research Center in May and June this year, a majority of scientists (51%)
HEALTH
August 24, 2011 | By Melissa Healy, Los Angeles Times
For patients with high levels of so-called bad cholesterol, doctors routinely reach for two remedies: cholesterol-lowering statin drugs and a diet that cuts out foods high in saturated fat, such as ice cream, red meat and butter. But new research has found that when it comes to lowering artery-clogging cholesterol, what you eat may be more important than what you don't eat. Released online Tuesday in the Journal of the American Medical Assn., the study found that incorporating several cholesterol-lowering foods — such as soy protein and nuts — into a diet can reduce bad cholesterol far more effectively than a diet low in saturated fat. In fact, the authors assert, levels of LDL, the "bad" cholesterol, can drop to half that seen by many patients who take statins, sold under such names as Lipitor, Crestor or Zocor.